13D Filing: Glaxosmithkline Plc and Innoviva Inc. (NASDAQ:INVA)

Page 5 of 6 – SEC Filing

SCHEDULE 1
Name
Business Address
Principal Occupation or Employment
Citizenship
Board of Directors
Emma Walmsley
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Executive Officer
British
Professor Sir Roy Anderson
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Independent Non-Executive Director & Scientific Expert
British
Manvinder Singh Banga
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Senior Independent Non-Executive Director
Indian
Dr. Patrick Vallance
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and President, R&D
British
Simon Dingemans
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Financial Officer
British
Lynn Elsenhans
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Independent Non-Executive Director
US
Dr. Jesse Goodman
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Independent Non-Executive Director & Scientific Expert
US
Sir Philip Hampton
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Non-Executive Chairman
British
Judy Lewent
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Independent Non-Executive Director
US
Urs Rohner
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Independent Non-Executive Director
Swiss
  Dr. Vivienne Cox
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
 Independent Non-Executive Director
 British

Follow Innoviva Inc. (NASDAQ:INVA)